Podcasts about Developmental biology

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?David: Unlocking potential.Biotech startups face daunting challenges, but David Kiewlich, Founder and CEO of Tomorrow Biotech Corporation, has created a model that flips the odds. While most startups face a 90% failure rate, David's incubator, Badass Labs, boasts an astounding 95% success rate.The secret? David's incubator takes on time-consuming tasks and provides founders with the tools and support they need to focus on high-value activities. “We take what I call low-value, high-risk tasks off of the responsibility of these early founders,” David explained. By handling procurement, accounting, and regulatory compliance, the incubator saves startups time, money, and frustration.For example, David shared how the incubator's full-service procurement system saves companies more than 70 hours of work while also cutting costs. “Because it's a pooled spend model, it allows us to be one giant customer instead of many little ones,” he said. This approach not only improves efficiency but also doubles the runway for many startups.David's focus goes beyond logistics—he's also deeply invested in coaching founders to grow. He emphasized the importance of coachability, saying, “If they are open to guidance and comfortable with being vulnerable, they'll grow.” This hands-on support ensures founders avoid rookie mistakes, expand their skill sets, and present their companies as professional and investor-ready.The work being done at Badass Labs and Tomorrow Biotech isn't just about improving success rates—it's about saving lives. By accelerating the development of biotech innovations, David's incubator is paving the way for groundbreaking ideas to reach the market faster.If you're inspired by David's approach and want to learn more about his incubator, visit badasslabs.org. With multiple locations across the U.S. and plans to expand, the program is open to biotech, climate tech, and other transformative startups. By helping founders focus on what matters most, David is proving that with the right support, startups can defy the odds and change the world.tl;dr:David Kiewlich's incubator flips the biotech startup success rate from 10% to 95% with unique support.The program removes tedious tasks, saving founders time and enabling them to focus on execution.Coachability is critical—David helps founders grow by fostering their confidence and guiding their development.David shared a superpower: unlocking potential by building up others and inspiring action.Tomorrow Biotech and Badass Labs accelerate innovation, empowering founders to bring life-saving ideas to market.How to Develop Unlocking Potential As a SuperpowerDavid Kiewlich's superpower is his ability to unlock the potential in others by fostering their confidence and helping them grow into their best selves. Reflecting on his life, David shared how he developed this skill early on, saying, “You become sort of focused on how you can lift up and protect everyone around you.” He uses this mindset to empower biotech founders, helping them become “superhumans” who think bigger, execute better, and achieve more.One inspiring story David shared highlights his superpower in action. Years ago, he organized a grassroots effort to rescue surplus food from wholesalers and deliver it to nonprofits across the San Francisco Bay Area. Over the course of a year, he single-handedly moved nearly 600,000 pounds of produce, ensuring it reached those in need instead of ending up in landfills. By showing what's possible, David inspired others to replicate his efforts, amplifying his impact.To develop this superpower, David suggests:Focus on building up others rather than seeking credit for yourself.Encourage people by expressing belief in their abilities.Help others see what's possible by setting an example.Support people in a way that allows them to focus on their strengths.By following David's example and advice, you can make unlocking potential a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileDavid Kiewlich (he/him):Founder and CEO, Tomorrow Biotech CorporationAbout Tomorrow Biotech Corporation: Tomorrow Biotech Corporation consists of an accelerator fund, an early stage fund and includes the Bay Area Disruptor and Startup Support Labs (BADASS Labs) a 501c3, non-profit series of biotech incubators. While the funds are new, the incubator has been in operation for 6 years, supporting dozens of pre-seed through series B (and beyond) companies. With a track record of 50 of 55 company successes for members of the incubator, this ecosystem has a uniquely successful approach to founder support, which has substantially changed the concept and expectations for early stage incubators. BADASS Labs is more than a 501c3, non-profit biotech incubator that rents lab space to small businesses. It is a strategic ally that empowers biotech entrepreneurs to achieve their full potential. By offering a comprehensive suite of services, such as purchasing, waste management, operations and even health insurance plans for its members, BADASS Labs enables its clients to focus on their core competencies and substantially reduce their operational costs. BADASS Labs bridges the gap between research and commercialization, by facilitating novel technologies from academic, national lab or self-generated sources into viable products that can enhance the domestic supply chain and generate regional employment. While we can incubate companies at any stage, we have a particular focus on the earlier side, from Pre-Seed through Series B stages.Website: badasslabs.org, TomorrowBiotech.com, MissionBoosterProcurement.comBiographical Information: Dr. David Kiewlich (Ph.D. in Cell and Developmental Biology) is a serial founder and entrepreneur in biotech. With over 35 years' experience working for industry, as well as 6 startups of his own (in Oncology, Cell Based Therapies and Synthetic Biology), his background is excellently aligned with the needs and struggles of pre-commercialization startups. He founded and runs Tomorrow Biotech, which includes the Bay Area Disruptor and Startup Support Labs (BADASS Labs) a 501c3, non-profit series of biotech incubators, which has supported dozens of pre-seed through series B (and beyond) companies, as well as a startup and early-stage fund. In addition to Tomorrow Biotech, David is also the CSO of a cell based therapy company, focused on autoimmune disease, advisor for several biotech startups and frequent public speaker advocating for increased sustainability and greater Diversity, Equity and Inclusion (DEI) in the sciences.LinkedIn Profile: linkedin.com/in/davidkiewlichSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, and Rancho Affordable Housing (Proactive). Learn more about advertising with us here to help us Power Up October.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on October 28, 2025, at 1:30 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, November 19, 2025, at 12:00 PM Eastern — Devin Thorpe, CEO and Founder of The Super Crowd, Inc., will lead a session on “Investing with a Self-Directed IRA.” In this session, Devin will explain how investors can use self-directed IRAs to participate in regulated investment crowdfunding while managing taxes and optimizing returns. He'll break down when this strategy makes sense, how to choose the right custodian, and what fees, rules, and risks to watch for. With his trademark clarity and real-world experience, Devin will help you understand how to balance simplicity with smart tax planning—so you can invest confidently, align your portfolio with your values, and make your money work harder for both impact and income.SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don't miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Impact Accelerator Summit is a live, in-person event taking place in Austin, Texas, from October 23–25, 2025. This exclusive gathering brings together 100 heart-centered, conscious entrepreneurs generating $1M+ in revenue with 20–30 family offices and venture funds actively seeking to invest in world-changing businesses. Referred by Michael Dash, participants can expect an inspiring, high-impact experience focused on capital connection, growth, and global impact.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?David: Unlocking potential.Biotech startups face daunting challenges, but David Kiewlich, Founder and CEO of Tomorrow Biotech Corporation, has created a model that flips the odds. While most startups face a 90% failure rate, David's incubator, Badass Labs, boasts an astounding 95% success rate.The secret? David's incubator takes on time-consuming tasks and provides founders with the tools and support they need to focus on high-value activities. “We take what I call low-value, high-risk tasks off of the responsibility of these early founders,” David explained. By handling procurement, accounting, and regulatory compliance, the incubator saves startups time, money, and frustration.For example, David shared how the incubator's full-service procurement system saves companies more than 70 hours of work while also cutting costs. “Because it's a pooled spend model, it allows us to be one giant customer instead of many little ones,” he said. This approach not only improves efficiency but also doubles the runway for many startups.David's focus goes beyond logistics—he's also deeply invested in coaching founders to grow. He emphasized the importance of coachability, saying, “If they are open to guidance and comfortable with being vulnerable, they'll grow.” This hands-on support ensures founders avoid rookie mistakes, expand their skill sets, and present their companies as professional and investor-ready.The work being done at Badass Labs and Tomorrow Biotech isn't just about improving success rates—it's about saving lives. By accelerating the development of biotech innovations, David's incubator is paving the way for groundbreaking ideas to reach the market faster.If you're inspired by David's approach and want to learn more about his incubator, visit badasslabs.org. With multiple locations across the U.S. and plans to expand, the program is open to biotech, climate tech, and other transformative startups. By helping founders focus on what matters most, David is proving that with the right support, startups can defy the odds and change the world.tl;dr:David Kiewlich's incubator flips the biotech startup success rate from 10% to 95% with unique support.The program removes tedious tasks, saving founders time and enabling them to focus on execution.Coachability is critical—David helps founders grow by fostering their confidence and guiding their development.David shared a superpower: unlocking potential by building up others and inspiring action.Tomorrow Biotech and Badass Labs accelerate innovation, empowering founders to bring life-saving ideas to market.How to Develop Unlocking Potential As a SuperpowerDavid Kiewlich's superpower is his ability to unlock the potential in others by fostering their confidence and helping them grow into their best selves. Reflecting on his life, David shared how he developed this skill early on, saying, “You become sort of focused on how you can lift up and protect everyone around you.” He uses this mindset to empower biotech founders, helping them become “superhumans” who think bigger, execute better, and achieve more.One inspiring story David shared highlights his superpower in action. Years ago, he organized a grassroots effort to rescue surplus food from wholesalers and deliver it to nonprofits across the San Francisco Bay Area. Over the course of a year, he single-handedly moved nearly 600,000 pounds of produce, ensuring it reached those in need instead of ending up in landfills. By showing what's possible, David inspired others to replicate his efforts, amplifying his impact.To develop this superpower, David suggests:Focus on building up others rather than seeking credit for yourself.Encourage people by expressing belief in their abilities.Help others see what's possible by setting an example.Support people in a way that allows them to focus on their strengths.By following David's example and advice, you can make unlocking potential a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileDavid Kiewlich (he/him):Founder and CEO, Tomorrow Biotech CorporationAbout Tomorrow Biotech Corporation: Tomorrow Biotech Corporation consists of an accelerator fund, an early stage fund and includes the Bay Area Disruptor and Startup Support Labs (BADASS Labs) a 501c3, non-profit series of biotech incubators. While the funds are new, the incubator has been in operation for 6 years, supporting dozens of pre-seed through series B (and beyond) companies. With a track record of 50 of 55 company successes for members of the incubator, this ecosystem has a uniquely successful approach to founder support, which has substantially changed the concept and expectations for early stage incubators. BADASS Labs is more than a 501c3, non-profit biotech incubator that rents lab space to small businesses. It is a strategic ally that empowers biotech entrepreneurs to achieve their full potential. By offering a comprehensive suite of services, such as purchasing, waste management, operations and even health insurance plans for its members, BADASS Labs enables its clients to focus on their core competencies and substantially reduce their operational costs. BADASS Labs bridges the gap between research and commercialization, by facilitating novel technologies from academic, national lab or self-generated sources into viable products that can enhance the domestic supply chain and generate regional employment. While we can incubate companies at any stage, we have a particular focus on the earlier side, from Pre-Seed through Series B stages.Website: badasslabs.org, TomorrowBiotech.com, MissionBoosterProcurement.comBiographical Information: Dr. David Kiewlich (Ph.D. in Cell and Developmental Biology) is a serial founder and entrepreneur in biotech. With over 35 years' experience working for industry, as well as 6 startups of his own (in Oncology, Cell Based Therapies and Synthetic Biology), his background is excellently aligned with the needs and struggles of pre-commercialization startups. He founded and runs Tomorrow Biotech, which includes the Bay Area Disruptor and Startup Support Labs (BADASS Labs) a 501c3, non-profit series of biotech incubators, which has supported dozens of pre-seed through series B (and beyond) companies, as well as a startup and early-stage fund. In addition to Tomorrow Biotech, David is also the CSO of a cell based therapy company, focused on autoimmune disease, advisor for several biotech startups and frequent public speaker advocating for increased sustainability and greater Diversity, Equity and Inclusion (DEI) in the sciences.LinkedIn Profile: linkedin.com/in/davidkiewlichSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, and Rancho Affordable Housing (Proactive). Learn more about advertising with us here to help us Power Up October.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on October 28, 2025, at 1:30 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, November 19, 2025, at 12:00 PM Eastern — Devin Thorpe, CEO and Founder of The Super Crowd, Inc., will lead a session on “Investing with a Self-Directed IRA.” In this session, Devin will explain how investors can use self-directed IRAs to participate in regulated investment crowdfunding while managing taxes and optimizing returns. He'll break down when this strategy makes sense, how to choose the right custodian, and what fees, rules, and risks to watch for. With his trademark clarity and real-world experience, Devin will help you understand how to balance simplicity with smart tax planning—so you can invest confidently, align your portfolio with your values, and make your money work harder for both impact and income.SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don't miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Impact Accelerator Summit is a live, in-person event taking place in Austin, Texas, from October 23–25, 2025. This exclusive gathering brings together 100 heart-centered, conscious entrepreneurs generating $1M+ in revenue with 20–30 family offices and venture funds actively seeking to invest in world-changing businesses. Referred by Michael Dash, participants can expect an inspiring, high-impact experience focused on capital connection, growth, and global impact.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

On October 9, 2025 we met with Maria Geffen to discuss the how three kinds of inhibitory neurons in the auditory cortex each contributes to individual features of auditory experience.Guest:Maria Geffen, Professor of Otorhinolaryngology, Neuroscience, and Neurology, University of PennsylvaniaParticipating:Alfonso Apicella, Department of Neuroscience, Regenerative and Developmental Biology, UTSAAlice Bertero, Department of Neuroscience, Regenerative and Developmental Biology, UTSAJon-Paul Moler, Department of Neuroscience, Regenerative and Developmental Biology, UTSAHost:Charles Wilson, Department of Neuroscience, Regenerative and Developmental Biology, UTSAThanks to James Tepper for original music

Text us a comment or question!We're living longer - but not healthier. Chronic disease, obesity, cancer, and cognitive decline are skyrocketing, and most of us have been led to believe it's all about food and fitness. But there's a deeper story hiding in plain sight. In this eye-opening conversation, Coach Kevin English sits down with Dr. Nathan Donley, a cellular biologist turned environmental health researcher, to uncover the truth about the toxins all around us - and inside us. From pesticide-laden crops to chemical-filled water and everyday household products, Dr. Donley reveals how corporate profits and weak policy have created an invisible health crisis. You'll learn what these chemicals are doing to your body, how they interact with diet and lifestyle, and why prevention (not treatment) should be the future of medicine. If you've ever felt like you're doing “everything right” but still struggling to feel vibrant and strong, this episode will change the way you think about health, aging, and personal responsibility. In This Episode You'll Discover:Why chronic disease rates keep climbing - even as science advancesThe shocking truth about what's really in your food, water, and soilHow modern agriculture and corporate lobbying shape the “standard” American dietThe difference between dirt and living soil (and why it matters for your health)How long-term exposure to small amounts of toxins can sabotage your body's ability to healWhy the solution isn't a “detox” - it's systemic change and smarter choicesWhat steps you can take today to reduce exposure and reclaim control over your health About Dr. Nathan DonleyDr. Donley earned his PhD in Cell and Developmental Biology at Oregon Health and Sciences University, where he studied how toxic chemicals damage DNA and lead to cancer. Today, he works with the Center for Biological Diversity, fighting to expose the health and environmental dangers of pesticides and chemical pollution - and pushing for stronger protections for people, wildlife, and the planet.Visit https://www.biologicaldiversity.org to learn more and take action.Instagram - https://www.instagram.com/centerforbiodiv/ 

Most of us will never have our insulin levels tested, yet this single hormone is the body's master regulator of energy. When it stops working properly, almost every system in the body is affected, from how we store fat, to how we age. Today's guest is Dr Ben Bikman, a scientist and world-leading expert on insulin and metabolism. He's a Professor in the Department of Physiology and Developmental Biology at Brigham Young University (BYU) and has spent years researching how changes inside our cells lead to common metabolic disorders, such as obesity, type 2 diabetes, and dementia. He frequently publishes his research in peer-reviewed journals, speaks at scientific conferences all over the world and is the author of 2 books, Why We Get Sick and How Not to Get Sick. In this conversation, we discuss: Why insulin is the body's “master hormone”, guiding how we store and use energy and how resistance to it can cause a wide range of chronic health problems. The fact that almost 9 in 10 adults show signs of poor metabolic health, and why this is a global issue that affects countries far beyond the United States. How ethnicity and genetics shape the way we store fat, explaining why two people of the same weight and size can face very different risks of conditions like type 2 diabetes or heart disease. Why focusing only on blood glucose misses the early warning signs of poor metabolic health, and why measuring insulin levels offers a clearer and earlier picture of risk. The visible clues your body may already be giving you – such as skin tags or darker, velvety patches of skin around the neck or armpits – that can indicate chronically elevated insulin. Practical strategies to bring insulin down, from reducing refined sugars and starches to spacing out meals and experimenting with fasting in ways that work for both men and women. So often, we're told that chronic illnesses are inevitable or a natural part of ageing. But as Ben explains, many of these conditions have a common origin – and by focusing on insulin resistance, we can take powerful steps towards prevention and even reversal. This conversation is not about fear, but empowerment. It's a reminder that our everyday choices – how and what we eat, how we move, and how often we give our bodies a rest from food – can profoundly influence our future health. I hope you enjoy listening. Support the podcast and enjoy Ad-Free episodes. Try FREE for 7 days on Apple Podcasts https://apple.co/feelbetterlivemore. For other podcast platforms go to https://fblm.supercast.com.   Thanks to our sponsors: https://www.vivobarefoot.com/livemore https://thriva.co/ https://www.boncharge.com/livemore   Show notes https://drchatterjee.com/582   DISCLAIMER: The content in the podcast and on this webpage is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on my website.

Dr. Anthea Mazzawi joins host Dr. Joel Berg to share her story as a dual pediatric dentist and orthodontist, a practice-owner and a mother. She delves into how the multifaceted roles have shaped her as a professional and leader, especially the opportunities to foster a network of peer experts. Dr. Mazzawi emphasizes the importance of a willingness to learn and Guest Bio: Dr. Anthea Mazzawi is a board-certified pediatric dentist who has practiced dentistry for almost 20 years. Raised along the gulf coast of Florida, she earned a B.S. degree in Developmental Biology from Florida State University and a D.M.D. degree from the University of Florida College of Dentistry. She then completed a residency in pediatric dentistry at the Medical University of South Carolina. She is currently in private practice with her husband, Dr. Miles Mazzawi, who is also a pediatric dentist. Their practice, Cherokee Children's Dentistry, has been serving the needs of children in the greater Atlanta area since 2007. Mazzawi is passionate about working with children and serving as an advocate for all child related issues. Mazzawi has been heavily involved with the American Academy of Pediatric Dentistry and organized dentistry throughout her career. She served as the president of The College of Diplomates of the American Board of Pediatric Dentistry in 2018 and has also been a part of several committees and councils for the American Academy of Pediatric Dentistry. Currently, she is the chairman of the Scientific Program Committee for the Annual Session. She also serves chairman of the Greater Atlanta Dental Foundation Gala Committee (an event that raises funds to meet the needs of several free/reduced fee clinics in Atlanta), and the secretary for the GA Academy of Pediatric Dentistry. Mazzawi is excited to serve as a trustee on the board of trustees for the AAPD. She looks forward to working with her colleagues, specifically the federal service membership, to promote for our profession and advance optimal oral health for all children. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, we talk with two authors who have papers featured in the special issue of the Journal of Genetic Counseling on Research Methods in Genetic Counseling. In the first segment we explore implementation science and its utilization in bridging the gap between research and clinical practice. In our second segment, we talk to an author about retrospective chart reviews and the benefits and drawbacks of this methodology.   Segment 1: A guide to utilizing implementation science for genetic counseling   Alanna Kulchak Rahm is a certified genetic counselor and implementation scientist with a PhD in Health and Behavioral Science. She has spent her career specializing in the implementation of genomics and precision health in healthcare systems. For over 25 years, she has conducted research on the utilization of genetic information by individuals and healthcare systems, new paradigms for identifying individuals with genomic risk, and new service delivery models for genomic testing. She has been a driver for the integration of implementation science and patient engagement to understand and study the integration of genomics into the learning health system, and is a tireless advocate of implementation science in genetic counseling. She has participated in and led many workshops and trainings on implementation science in genetics, serving as a faculty mentor for the NIH Training in Dissemination and Implementation Research in Cancer (TIDIRC) and recently as a co-lead of the Training in Dissemination and Implementation Research in Genomics and Precision Public Health (TIDIR-GPPH). She is currently a Program Director in the Division of Genomic Medicine at the National Human Genome Institute (NHGRI) where she directs the Network of Genomics-Enabled Learning Health Systems and other programs and continues to advance the integration of implementation science and genomics.   In this segment we discuss: Implementation science (IS) as a bridge between research and clinical practice in genetic counseling Misconceptions about IS, key frameworks like RE-AIM, and practical applications in daily work Using IS to identify and reduce inequities in genomic medicine Future integration of IS into training, research, and professional practice Link to the 2025 annual conference on dissemination and implementation    Segment 2: Leveraging hindsight: A retrospective chart review how-to for genetic counselors   Dr. Ramsey is the Section Chief of Individualized Therapeutics in the Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation at Children's Mercy. She is leading the implementation of a pharmacogenomics program that is fully integrated with the electronic health record, developing model-informed decision support for several medications, and Co-director of their Pediatric Clinical Pharmacology Fellowship Program. Before joining Children's Mercy, Dr. Ramsey was an Associate Professor and co-director of the Genetic Pharmacology Service at Cincinnati Children's Hospital. She completed her postdoctoral fellowship in Pharmacogenetics at St. Jude Children's Research Hospital and received her PhD in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota – Twin Cities. Dr. Ramsey is interested in all aspects of pharmacogenetics, from basic research to implementation in patient care.   In this segment we discuss: The role of retrospective chart reviews in genetic counseling research Common pitfalls such as unclear aims, time demands, and data extraction challenges Strategies for success, including SOPs, REDCap, and multidisciplinary collaboration Lessons learned on refining criteria, ensuring data quality, and team engagement   Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Stephanie Schofield. 

Professor Jane Sowden, Professor of Developmental Biology and Genetics at University College London (UCL) Great Ormond Street Institute of Child Health

My guest today on the Online for Authors podcast is Twila Mason, author of the book Piece by Piece.  Twila is an award-winning romance author. She has been writing her own stories since she learned how to read. She is a writer of romance, women's fiction, poetry, and short stories. Her work explores raw emotions and the complexities of life while finding the hope within every obstacle.   After obtaining a PhD in Cell and Developmental Biology, she switched gears to follow her lifelong dream of putting her fictional stories out into the world. She lives the rural, small-town life in Missouri with her husband, two kids, and menagerie of animals. When she's not reading or writing, Twila can be found crafting, farming, doing home improvement projects, or going on adventures with her family.   In my book review, I stated Piece by Piece is a friends-to-lovers contemporary romance that takes a hard look at the drug culture - and what it does to families. Aria spends her childhood looking after her baby brother, Ben, because her mother simple cannot. As a drug addict, she is often high, always unreliable, and rarely offers motherly support. When her mother spends the rent money, Aria arrives home to find the family is now on the street. She turns to an old friend, Luke, who found a way out of the old neighborhood.   Although there is an immediate spark between them, Luke and Aria dance around the attraction because neither is ready to commit. We get front row seats as we watch them battle their demons and navigate a new world where peace, hope, and love have a chance to exist. As completely foreign concepts, neither one really knows what to do when life isn't a battlefield.   That's not to say everything is easy. Moving past trauma and finding the right path is not easy. Nor is forgiveness - of others or of self. And what to do when the ones you should love are the ones that keep hurting you?   This story is sweet as two young people fall in love. But it is also edgy as we see what happens when drugs and alcohol cause childhood trauma and can easily create a family cycle of abuse.   Subscribe to Online for Authors to learn about more great books! https://www.youtube.com/@onlineforauthors?sub_confirmation=1   Join the Novels N Latte Book Club community to discuss this and other books with like-minded readers: https://www.facebook.com/groups/3576519880426290   You can follow Author Twila Mason Website: https://www.twilamason.com FB:@twilamasonauthor IG: @twilamason_author X: @twilamasona LinkedIn: @twila-mason-phd-3b824330   Purchase Piece by Piece on Amazon: Paperback: https://amzn.to/4lhAvHY Ebook: https://amzn.to/4kq9XDg   Teri M Brown, Author and Podcast Host: https://www.terimbrown.com FB: @TeriMBrownAuthor IG: @terimbrown_author X: @terimbrown1   Want to be a guest on Online for Authors? Send Teri M Brown a message on PodMatch, here: https://www.podmatch.com/member/onlineforauthors   #twilamason #piecebypiece #contemporaryromance #friendstolovers #terimbrownauthor #authorpodcast #onlineforauthors #characterdriven #researchjunkie #awardwinningauthor #podcasthost #podcast #readerpodcast #bookpodcast #writerpodcast #author #books #goodreads #bookclub #fiction #writer #bookreview *As an Amazon Associate I earn from qualifying purchases.

In this episode, Lisa, Dr. Corbin, and Catie discuss:Mentorship as a driver of growth and opportunityThe mutual responsibilities within mentor–mentee relationshipsEarly guidance shaping confidence and career directionPaying forward lessons learned through mentoring othersKey Takeaways: Mentorship offers students personalized support, creating opportunities that money alone cannot provide.Advocating for oneself and asking for help early—whether in high school classrooms or college —can build the confidence needed to persist in challenging subjects.Successful mentorship is not about rigid schedules but about mentees taking initiative, showing preparedness, and seeking guidance when it's most needed.Recognition can follow when students demonstrate leadership by mentoring younger peers, developing rigorous learning systems, and fostering strong academic communities.“If you're a scientist in the STEM field, and you've never mentored anybody… I promise that any effort and time you spend mentoring will be rewarding, both for your mentee and for you.” – Dr. Karen Corbin“Mentorship has always been a really important aspect of my life, and I do think something I'm very good at is advocating for myself and asking for help.” – Catie KeanAbout Dr. Karen Corbin and Catie Kean: Dr. Karen Corbin is an Associate Investigator at the AdventHealth Translational Research Institute. Since August 2024, she has mentored Catie Kean through the Astronaut Scholarship Foundation, supporting her academic journey and professional development.Catie Kean is a 2024 Astronaut Scholar with the Astronaut Scholarship Foundation and a recent graduate with a Bachelor of Science in Biology and Biotechnology. She earned an Honorable Mention for the NSF Graduate Research Fellowship Program and will begin her PhD in Molecular, Cellular, and Developmental Biology at the University of Colorado Boulder in August 2025.Episode References:Explore more resources to support students' growth and clarity by visiting the free tools Join ASF's Mentorship Program to support the newly announced 2025 Astronaut Scholars and help shape the future of scienceGet Lisa's Free on-demand video: How-to guide for your teen to choose the right major, college, & career...(without painting themselves into a corner, missing crucial deadlines, or risking choices you both regret). Connect with the Astronaut Scholarship Foundation:Instagram: https://www.instagram.com/astroscholarfdn/?hl=en Facebook: https://www.facebook.com/AstroScholarFdn/LinkedIn: https://www.linkedin.com/company/astronaut-scholarship-foundation/Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoFacebook: https://www.facebooke.com/flourishcoachingco/Instagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

On this episode, Erik Wallenberg and Joshua Frank talk to Nafis Hasan about his new book, Metastasis: The Rise of the Cancer-Industrial Complex and the Horizons of Care. Nafis Hasan received his PhD in Cell, Molecular and Developmental Biology from Tufts University in 2019. He is currently an Associate Faculty at the Brooklyn Institute for More The post The Cancer-Industrial Complex w/ Nafis Hasan appeared first on CounterPunch.org.

Welcome to The Future Conceived, the official podcast of the Society for the Study of Reproduction! In this episode, host Cam Schmidt has a fascinating conversation with Dr. Marisa Bartolomei, Perlman Professor of Cell and Developmental Biology at the University of Pennsylvania and the esteemed winner of SSR's 2025 Training Mentoring Award.Dr. Bartolomei shares insights into her unique journey, transitioning into reproductive biology as a faculty member after starting in other fields like genetics and epigenetics. She discusses the evolution of graduate and postdoctoral training, the challenges of navigating an ever-growing sea of scientific information, and the increasing length of PhD and postdoc programs. Listen in as she reflects on her diverse mentorship experiences, from her early days knocking on lab doors as an undergraduate to her current approach of fostering not only research skills but also crucial "soft skills" in her trainees.Discover what Dr. Bartolomei finds most rewarding about mentoring, her advice for early career scientists starting their own labs, and essential tips for trainees on how to navigate their scientific journeys. This episode offers a candid and insightful look into the past, present, and future of scientific training and mentorship within the reproductive sciences.Sponsored by SSR's Virtual Education Committee, dedicated to education, highlighting member careers, and sharing the latest scientific advancements in reproductive biology. Learn more at ssr.org.

In today's OncClub episode, we had the pleasure of speaking with Branden Moriarity, PhD; and Beau Webber, PhD, about a study evaluating neoantigen-reactive CISH knockout tumor-infiltrating lymphocyte (TIL) therapy in patients with metastatic gastrointestinal cancers. Dr Moriarity is an associate professor in the Division of Pediatric Hematology/Oncology, co-director of the Center for Genome Engineering and the Genome Engineering Shared Resource (GESR), and a member of the Center for Genome Engineering at the University of Minnesota in Minneapolis, where he is also a faculty member in the Department of Pediatrics; the Microbiology, Immunology and Cancer Biology (MICaB) PhD Graduate Program; the PhD Program in Molecular, Cellular, Developmental Biology and Genetics; the Cellular and Molecular Biology (CMB) Graduate Program, and the Masters Program in Stem Cell Biology. He is also a member of the Stem Cell Institute at the Masonic Cancer Center. Dr Webber is an associate professor in the Division of Pediatric Hematology/Oncology, co-director of the GESR, and a member of the Stem Cell Institute at the University of Minnesota Medical School, where he is also a faculty member in the Department of Pediatrics, the Molecular Pharmacology & Therapeutics Graduate Program, and the Masters Program in Stem Cell Biology. He is also a member of the Masonic Cancer Center. In our exclusive interview, Drs Moriarity and Webber discussed how targeting the CISH gene using CRISPR enhances T-cell function, key safety and efficacy findings from this study in 12 patients, and future research efforts that may focus on reducing manufacturing time and cost, as well as enhancing T-cell resilience. Check out the full OncClub subseries to see additional findings and insights from this research!

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

Scientists, leaders, and patients discuss the intersection of cutting-edge science and real-world impact. They explore the importance of patient perspectives in shaping medical advancements and how collaboration fuels groundbreaking research. Key scientific achievements in areas like regenerative medicine, cancer therapies, and space biology are highlighted. The group emphasizes the need for scientists to engage more with the public—through social media and media appearances—to help people understand and value the life-changing discoveries in science. Featuring: Catriona Jamieson, M.D., Ph.D. UC San Diego Sandra Dillon Patient Advocate Alexander Khalessi, M.D., M.B.A. UC San Diego Jana Stoudemire Celestial Strategy, LLC Alysson Muotri, Ph.D. UC San Diego Rebecca Moores Philanthropist and Patient Advocate Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40519]

The placenta is essential for life, but so much of its function is unknown. In this episode, we talk about how this disposable organ's development within the early weeks of pregnancy shapes so much of what happens months later. We tackle what makes the human placenta so unique, what other animals like reptiles are teaching us about it, and how scientists are turning to evolution and computer models to see if we can better understand it.Check out the IVF episode of Tiny Matters.Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Link to the Tiny Show & Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Doug Lucas sits down with Dr. Stuart Kim, a geneticist and former Professor of Genetics and Developmental Biology at Stanford University, to explore the powerful role genetics plays in osteoporosis. They discuss the founding of AxGen, the company Dr. Kim created to bring genetic testing into the forefront of osteoporosis care. Together, they dive into how understanding genetic risk can transform prevention strategies, personalize treatment plans, and ultimately improve outcomes. The conversation also highlights the importance of early screening and the potential economic benefits of using genetic testing to more efficiently manage chronic disease.Dr. Stuart KimWebsite: https://www.axgen.us

Guest: Lisa Baik, Postdoctoral researcher with the Department of Molecular, Cellular and Developmental Biology at Yale University

Parent-specific epigenetic marks (imprints) leading to parent-specific gene expression are crucial for normal growth and development, yet their mechanisms of establishment and maintenance are not fully understood. In humans, approximately 200 imprinted genes have been discovered, and improper imprinting can manifest in growth restriction, obesity, intellectual disabilities, behavioral abnormalities, and an increased risk of certain cancers. While the use of pluripotent stem cells, especially those in the naïve state, have advanced aspects of modeling early development, a persistent issue hampering bona fide naïve hPSCs is the erosion of imprints. Our guests on today's episode will discuss genomic imprinting, its function, impact, and a new reporter system of imprinted gene expression in hPSCs that enables real-time visualization of loss-of-imprinting at single-cell resolution. This assay provides an important tool to help discover how to improve the imprint fidelity of naïve hPSCs and hence their application for studies of human development and regeneration. Guests Thorold Theunissen, PhD, Department of Developmental Biology, Washington University in St Louis, USA Gal Keshet, The Azrieli Center for Stem Cells and Genetic Research, The Hebrew University of Jerusalem, IsraelSupporting ContentTracking and mitigating imprint erasure during induction of naïve human pluripotency at single-cell resolutionHostJanet Rossant, Editor-in-Chief, Stem Cell Reports and The Gairdner FoundationAbout Stem Cell ReportsStem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.X: @StemCellReportsAbout ISSCRWith nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.ISSCR StaffKeith Alm, Chief Executive OfficerYvonne Fisher, Managing Editor, Stem Cell ReportsKym Kilbourne, Director of Media and Strategic CommunicationsMegan Koch, Senior Marketing ManagerJack Mosher, Scientific AdvisorHunter Reed, Senior Marketing CoordinatorVoice WorkBen Snitkoff

Listener to the show, Elaine, wants to know whether her mother, who was a thalidomide baby, might have passed on effect of the drug to her children. Thalidomide was a treatment for morning sickness which caused severe birth differences in children born to mothers who used the drug. James Tytko sought an answer, with help from Neil Vargesson, Professor of Developmental Biology at the University of Aberdeen... Like this podcast? Please help us by supporting the Naked Scientists

At the Artificiality Summit 2024, Michael Levin, distinguished professor of biology at Tufts University and associate at Harvard's Wyss Institute, gave a lecture about the emerging field of diverse intelligence and his frameworks for recognizing and communicating with the unconventional intelligence of cells, tissues, and biological robots. This work has led to new approaches to regenerative medicine, cancer, and bioengineering, but also to new ways to understand evolution and embodied minds. He sketched out a space of possibilities—freedom of embodiment—which facilitates imagining a hopeful future of "synthbiosis", in which AI is just one of a wide range of new bodies and minds. Bio: Michael Levin, Distinguished Professor in the Biology department and Vannevar Bush Chair, serves as director of the Tufts Center for Regenerative and Developmental Biology. Recent honors include the Scientist of Vision award and the Distinguished Scholar Award. His group's focus is on understanding the biophysical mechanisms that implement decision-making during complex pattern regulation, and harnessing endogenous bioelectric dynamics toward rational control of growth and form. The lab's current main directions are: - Understanding how somatic cells form bioelectrical networks for storing and recalling pattern memories that guide morphogenesis; - Creating next-generation AI tools for helping scientists understand top-down control of pattern regulation (a new bioinformatics of shape); and - Using these insights to enable new capabilities in regenerative medicine and engineering. www.artificiality.world/summit

Nadia Davari is an entertainment attorney with extensive experience across a spectrum of fields including film, television (both scripted and unscripted), documentaries, music, influencer branding, technology, fashion, and startups. She is known for her dynamic legal counsel and has also expanded her portfolio by executive producing and producing several notable projects. Some of her credits include "Senior Moment," "All There Is," "Harpoon," "Here's Yianni," "A Motel," "Workaholics," and "The Crusades."Ms. Davari's legal and production expertise is complemented by her active participation in educational and industry panels. She has shared her knowledge at prestigious institutions and events, including the USC School of Cinematic Arts, the USC School of Law's Entertainment Law Symposium, Southwestern Law School, UCLA School of Law, and Raindance LA Film School. She has also been a keynote speaker and panel moderator at renowned industry gatherings like Hollywood Women's Film Festival, Wonder Women Tech, Dances with Films, The Multi Cultural Film Festival, Bet Tzedek Legal Services, and the ScareLA horror convention.Ms. Davari earned her J.D. from the University of Southern California's School of Law. Her undergraduate education was completed at the University of California, Los Angeles, where she received a Bachelor of Science in Molecular, Developmental Biology, and Genetics—demonstrating her ability to bridge the worlds of science and entertainment with her diverse skill set.

In this special edition of the podcast, we will talk with the new Editor-in-Chief Janet Rossant and hear about her vision for the journal, its promising future, and what she sees as some of the exciting prospects over the horizon for stem cell research. We will also talk with Yvonne Fisher, the journal's Managing Editor, and Jack Mosher of the ISSCR, about the evolution of the journal and its role in the Society. GuestsJanet Rossant is the new Editor-in-Chief of Stem Cell Reports. She holds an appointment as the Chief of Research Emeritus and Senior Scientist at The Hospital for Sick Children and is the President and Scientific Director of the Gairdner Foundation. Widely recognized as an expert in embryonic development, Professor Rossant has been recognized for her contributions to science with awards, including the Ross G. Harrison Medal (lifetime achievement award) from the International Society of Developmental Biologists, the March of Dimes Prize in Developmental Biology, the Conklin Medal from the Society for Developmental Biology, and the 2018 L'Oréal For Women in Science Award. She is a Fellow of the Royal Societies of both London and Canada, and an International member of the US National Academy of Sciences. She previously served as President of the ISSCR. Learn more about Stem Cell Reports editorial team. Yvonne Fisher is the Managing Editor of Stem Cell Reports. Yvonne received her PhD from Frankfurt University and did her postdoctoral work in the laboratory of Henrik Semb at the University of Lund in Sweden. Yvonne is the longest serving member of the journal, serving as Managing Editor since the journal's inception in 2012. Jack Mosher is the Scientific Advisor for the International Society for Stem Cell Research. He received his PhD from the University of North Carolina in Chapel Hill and was a postdoctoral fellow in the laboratory of Sean Morrison at the University of Michigan. Jack serves numerous roles for the Society including administrative oversight of Stem Cell Reports.  HostMartin Pera, Editor-in-Chief, Stem Cell Reports and The Jackson LaboratoryX: @martinperaJAXAbout Stem Cell ReportsStem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.X: @StemCellReportsAbout ISSCRWith nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.ISSCR StaffKeith Alm, Chief Executive OfficerYvonne Fisher, Managing Editor, Stem Cell ReportsKym Kilbourne, Director of Media and Strategic CommunicationsMegan Koch, Marketing ManagerJack Mosher, Scientific AdvisorHunter Reed, Senior Marketing CoordinatorVoice WorkBen Snitkoff

University of Washington の浜崎伸彦さん(@Nobu_Hamazaki)がゲスト。Human RA-Gastruloid論文、条件探索のコツ、ステージング問題、卵子形成論文、PI生活、今後目指す合成的発生生物学の方向性など (12/12収録) Show Notes (番組HP): 浜崎ラボHP 博士課程(の後半)での所属ラボ：中島欽一ラボ 日本での所属ラボ：林克彦ラボ (現在は阪大) 日本にいたときの卵子形成転写因子論文 かぐや論文 Parthenogenesisのレビュー 留学先の所属ラボ：Jay Shendureラボ 留学先でのHuman RA-Gastruloid論文 最初にあったマウスGastruloid論文 Matrigel おすすめの発生生物学の教科書ギルバート発生生物学、ウォルパート発生生物学とラングマン人体発生学とそのムービー JayのGestalt イベントのレコーディング シュペーマンのオーガナイザー (pdf) Turner Syndrome Wntアゴニストのカイロン 下流のBrachyury (T)という転写因子 最近出ていた脊索が現れる3D trunk organoid論文 bioRxivに最初に出た論文 とその数日後にアップロードされた競合論文 その１ ２ ３ ４ の出版論文としての結果 1 2 3 4 最近溜まっているEmbryonic single cell data 1 2 3 4 5 6 7 10x sci-RNA-seq3 Smart-seq3 Wei Yangさん（Jayラボメンバーページ） マーカージーンをGPTに入れると予測してくる Mappingする方法  UMAPのco-embedding Foundation modelを作っていく例 今村さん とやっていたgene regulation Zygotic genome activation 精子のヒストンがプロタミンに置き換わる機構 残ったヒストンがinter-generationalなepigenetic memoryに関与する？（pdf） 父が肥満だと子が肥満になりやすい、母だとそうでもない ダーウィン vs ルイセンコ iPSで精子作成している例 減数分裂？に関するプレプリント パキテンで止まっている 山中論文は24から4へ 卵子が大きくなるためにはアクアポリンが必要。

View the Show Notes For This Episode Dr. Tom Fabian discusses Myths and Misconceptions about Stool Testing with Dr. Ben Weitz. [If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]   Podcast Highlights In this episode of the Rational Wellness Podcast, Dr. Ben Weitz interviews Dr. Tom Fabian from Diagnostic Solutions about the various methodologies of stool testing, including culture, Whole Genome Shotgun Sequencing, and Quantitative PCR. The discussion primarily focuses on the GI MAP test, a popular stool test in functional medicine, which uses quantitative PCR to provide insights into the microbiome, pathogens, and gut health. Dr. Fabian explains the science behind PCR and addresses common concerns about stool testing, the detection of pathogens like H. pylori and C. difficile, and how stool tests can give clues to conditions like small intestinal bacterial overgrowth and leaky gut. The episode also delves into broader implications of stool tests for clinical practice and patient care.   00:26 Interview with Dr. Tom Fabian on Stool Testing 00:40 Understanding Stool Testing Methodologies 03:19 Quantitative PCR and Its Advantages 08:10 Comparing Stool Testing Methods 17:13 The Importance of Quantitative Data in Clinical Settings 19:47 Addressing Criticisms of PCR Testing 22:58 Promotional Break: Apollo Wearable 24:30 Asymptomatic Colonization and C. diff 28:00 Understanding C. diff and Its Risk Factors 29:17 The Role of Parasites in Gut Health 32:40 Controversies Around H. pylori Detection 38:59 Small Intestine and GI MAP Insights 41:31 Methane and Small Intestinal Bacterial Overgrowth (SIBO) 45:58 Inflammation and Gut Health Markers 51:27 Final Thoughts and Resources for Practitioners     Dr. Tom Fabian has a PhD in Molecular, Cellular, and Developmental Biology and he is a certified Nutrition Therapy Practitioner. Tom specializes in the microbiome and how it relates to digestive, immune, brain, and metabolic health.  Dr. Fabian serves a consultant and science advisor with Diagnostic Solutions Laboratory.  DiagnosticSolutionsLab.com. Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.  

Michael Levin is a Distinguished Professor in the Biology department at Tufts University and associate faculty at the Wyss Institute for Bioinspired Engineering at Harvard University. Prof Levin holds the Vannevar Bush endowed Chair and serves as director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. Prior to college, Michael Levin worked as a software engineer and independent contractor in the field of scientific computing. He attended Tufts University, interested in artificial intelligence and unconventional computation. To explore the algorithms by which the biological world implemented complex adaptive behavior, he got dual B.S. degrees, in CS and in Biology and then received a PhD from Harvard University. He did post-doctoral training at Harvard Medical School, where he began to uncover a new bioelectric language by which cells coordinate their activity during embryogenesis. His independent laboratory develops new molecular-genetic and conceptual tools to probe large-scale information processing in regeneration, embryogenesis, and cancer suppression. Lecture Title: "Where Minds Come From: The Scaling of Collective Intelligence. What it means for AI and You." Special thanks to Mike for allowing me to share this lecture with the MBS audience. EPISODE LINKS: - Mike's Round 1: https://youtu.be/v6gp-ORTBlU - Mike's Round 2: https://youtu.be/kMxTS7eKkNM - Mike's Round 3: https://youtu.be/1R-tdscgxu4 - Mike's Channel: https://www.youtube.com/@drmichaellevin - Mike's Website: https://drmichaellevin.org/ CONNECT: - Website: https://tevinnaidu.com - Podcast: https://podcasters.spotify.com/pod/show/drtevinnaidu - Twitter: https://twitter.com/drtevinnaidu - Facebook: https://www.facebook.com/drtevinnaidu - Instagram: https://www.instagram.com/drtevinnaidu - LinkedIn: https://www.linkedin.com/in/drtevinnaidu ============================= Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

Dr. Barbara Katzenback is an Assistant Professor in the Department of Biology at the University of Waterloo. Barb studies how frogs defend themselves from diseases to stay alive, and she also investigates how the environments that frogs live in impact their ability to defend against diseases. Frogs and other amphibians are critical components of the food web, they are important for pest control, they are indicators for the health of their environment, and they produce interesting molecules on the surface of their skin that may have relevance for human health. Barb's hobbies outside of science include engaging in a variety of physical activities like running, yoga, and hiking with her husband and two dogs. She's also experimented with soccer, spin classes, cross country skiing, rock climbing, and inner tube water polo. Some of her other interests include pottery, art, crafting, baking, gardening, sewing, and leisure reading. Barb earned her BSc with Honors in Immunology and Infection from the University of Alberta. She received her PhD in Physiology, Cell, and Developmental Biology from the University of Alberta as well. Barb was next awarded a Natural Sciences and Engineering Research Council (NSERC) Postdoctoral Fellowship to conduct research at Carleton University, followed by an NSERC Banting Postdoctoral Fellowship to conduct research at the University of Waterloo before joining the faculty there. In our interview, Barb speaks more about her experiences in life and science.

******Support the channel****** Patreon: https://www.patreon.com/thedissenter PayPal: paypal.me/thedissenter PayPal Subscription 1 Dollar: https://tinyurl.com/yb3acuuy PayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9l PayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpz PayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9m PayPal Subscription 20 Dollars: https://tinyurl.com/y95uvkao   ******Follow me on****** Website: https://www.thedissenter.net/ The Dissenter Goodreads list: https://shorturl.at/7BMoB Facebook: https://www.facebook.com/thedissenteryt/ Twitter: https://x.com/TheDissenterYT   This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/   Dr. Michael Levin is Distinguished Professor in the Biology Department and Vannevar Bush Chair, as well as director of the Tufts Center for Regenerative and Developmental Biology at Tufts University. His work is focused on understanding the biophysical mechanisms that implement decision-making during complex pattern regulation, and harnessing endogenous bioelectric dynamics toward rational control of growth and form.   In this episode, we go through topics like living systems; self; planaria; morphology; cognition, and collective intelligence; multiscale competency; mind and sentience; regenerative medicine; cancer; and life after death. -- A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: PER HELGE LARSEN, JERRY MULLER, BERNARDO SEIXAS, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, FILIP FORS CONNOLLY, ROBERT WINDHAGER, RUI INACIO, ZOOP, MARCO NEVES, COLIN HOLBROOK, PHIL KAVANAGH, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, FERGAL CUSSEN, HAL HERZOG, NUNO MACHADO, JONATHAN LEIBRANT, JOÃO LINHARES, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, ROMAIN ROCH, DIEGO LONDOÑO CORREA, YANICK PUNTER, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, NELLEKE BAK, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, EDWARD HALL, HEDIN BRØNNER, DOUGLAS FRY, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, SCOTT, ZACHARY FISH, TIM DUFFY, SUNNY SMITH, JON WISMAN, WILLIAM BUCKNER, PAUL-GEORGE ARNAUD, LUKE GLOWACKI, GEORGIOS THEOPHANOUS, CHRIS WILLIAMSON, PETER WOLOSZYN, DAVID WILLIAMS, DIOGO COSTA, ALEX CHAU, AMAURI MARTÍNEZ, CORALIE CHEVALLIER, BANGALORE ATHEISTS, LARRY D. LEE JR., OLD HERRINGBONE, MICHAEL BAILEY, DAN SPERBER, ROBERT GRESSIS, IGOR N, JEFF MCMAHAN, JAKE ZUEHL, BARNABAS RADICS, MARK CAMPBELL, TOMAS DAUBNER, LUKE NISSEN, KIMBERLY JOHNSON, JESSICA NOWICKI, LINDA BRANDIN, GEORGE CHORIATIS, VALENTIN STEINMANN, PER KRAULIS, ALEXANDER HUBBARD, BR, JONAS HERTNER, URSULA GOODENOUGH, DAVID PINSOF, SEAN NELSON, MIKE LAVIGNE, JOS KNECHT, LUCY, MANVIR SINGH, PETRA WEIMANN, CAROLA FEEST, MAURO JÚNIOR, 航 豊川, TONY BARRETT, BENJAMIN GELBART, NIKOLAI VISHNEVSKY, STEVEN GANGESTAD, AND TED FARRIS! A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, TOM VANEGDOM, BERNARD HUGUENEY, CURTIS DIXON, BENEDIKT MUELLER, THOMAS TRUMBLE, KATHRINE AND PATRICK TOBIN, JONCARLO MONTENEGRO, AL NICK ORTIZ, NICK GOLDEN, AND CHRISTINE GLASS! AND TO MY EXECUTIVE PRODUCERS, MATTHEW LAVENDER, SERGIU CODREANU, BOGDAN KANIVETS, ROSEY, AND GREGORY HASTINGS!

Michael Levin is an American developmental and synthetic biologist at Tufts University, where he is the Vannevar Bush Distinguished Professor. Levin is a director of the Allen Discovery Center at Tufts University and Tufts Center for Regenerative and Developmental Biology. Key HighlightsDiscussion of diverse intelligence in biological systems and its biomedical potentialInsights into planarian regeneration and collective problem-solvingAnatomical plasticity and the role of bioelectric interfacesApplying these principles to regenerative medicine and synthetic biologyHow living structures can adapt and solve complex problems – leading to breakthroughs in organ regeneration, cancer treatment, and mental healthAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

Michael Levin is an American developmental and synthetic biologist at Tufts University, where he is the Vannevar Bush Distinguished Professor. Levin is a director of the Allen Discovery Center at Tufts University and Tufts Center for Regenerative and Developmental Biology. Key HighlightsDiscussion of diverse intelligence in biological systems and its biomedical potentialInsights into planarian regeneration and collective problem-solvingAnatomical plasticity and the role of bioelectric interfacesApplying these principles to regenerative medicine and synthetic biologyHow living structures can adapt and solve complex problems – leading to breakthroughs in organ regeneration, cancer treatment, and mental healthAbout Foresight InstituteForesight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison DuettmannThe President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".Get Involved with Foresight:Apply to our virtual technical seminars Join our in-person events and workshops Donate: Support Our Work – If you enjoy what we do, please consider this, as we are entirely funded by your donations!Follow Us: Twitter | Facebook | LinkedInNote: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine. Hosted on Acast. See acast.com/privacy for more information.

In EPISODE 182 OF GROWING OLDER LIVING YOUNGER, Dr. Thomas Weimbs and Dr. Gillian Lockitch  discuss the prevalence and management of chronic kidney disease (CKD), which affects one in seven adults in the U.S. Dr. Weimbs highlights the importance of diet and lifestyle in managing CKD, particularly through ketogenic metabolic therapy. He explains that ketosis, induced by a low-carbohydrate diet, can slow the progression of polycystic kidney disease (PKD) by reducing inflammation and improving kidney function. Dr. Weimbs  describes the Ren-Nu program, a three-month nutrition and lifestyle intervention for kidney disease patients, which has shown significant improvements in kidney function and pain reduction for many participants. Whether you're affected by kidney disease, have a family history, or are simply interested in how nutrition and epigenetic strategies can support healthy aging, this episode will provide invaluable insights.  Thomas Weimbs PhD is a leading expert in kidney disease research. He is a professor at the University of California in Santa Barbara (UCSB) where he directs a research laboratory focused on polycystic kidney disease. He received his doctoral degree from the University of Cologne, Germany, and then conducted postdoctoral research at the University of California in San Francisco. In 1999, as an assistant professor, he started his first independent research laboratory at the Lerner Research Institute of the Cleveland Clinic. There, his research on polycystic kidney disease began with the support of a local family affected by PKD and whose family foundation still supports PKD research in Dr. Weimbs' lab today. In 2005, Dr. Weimbs moved his laboratory back to California to join the Department of Molecular, Cellular, and Developmental Biology at UCSB. The laboratory studies molecular mechanisms underlying PKD with an emphasis towards developing new therapies. Recent research has led to the discovery that dietary interventions and natural metabolites strongly slow PKD progression in animal models. This led to the launch of Santa Barbara Nutrients with the goal to make these approaches available for the nutritional management of PKD. Episode Timeline: 0:01 Introduction to kidney disease 3:16 Introduction of Dr.Thomas Weimbs 8:16 Overview of Kidney Function and Importance 13:36 Screening and Early Detection of Kidney Disease 21:51 Genetic and Sporadic Cases of Polycystic Kidney Disease (PKD) 24:11 Ketogenic Metabolic Therapy for PKD 30:41 Mechanism and Effectiveness of Ketosis 33:30 Assessing Ketosis, and Dietary Recommendations 38:38 Nutrition and Lifestyle Intervention Program (Ren-Nu Program) 41:48 Challenges and Future Directions in Kidney Disease Research Action Steps: Schedule a free  Growing Older Living Younger CALL with Dr. Gillian Lockitch.   Join the online Growing Older Living Younger Community: https://www.facebook.com/groups/growingolderlivingyounger Learn about Dr. Thomas Weimbs and PKD research Lab Facebook group  https://www.facebo UCSB lab website: https://labs.mcdb.ucsb.edu/weimbs/thomas/ ok.com/groups/weimbslab/ The Ren-Nu nutrition and lifestyle program https://ren-nu.org  https://santabarbaranutrients.com Youtube channel: https://www.youtube.com/@SantaBarbaraNutrients Get to know Your Host: Dr. Gillian Lockitch website: https://www.askdrgill.com/.  Meta: https://www.facebook.com/gillian.lockitch/ LinkedIn: https://www.linkedin.com/in/gillianlockitch/ X: https://twitter.com/GilliansReviews

In this conversation, Professor Alex Tups discusses his extensive research on metabolic regulation, focusing on the roles of leptin and insulin in the brain. He shares insights into the discovery of butane, a compound found in the Dahlia flower, and its potential to improve blood sugar regulation and combat neuroinflammation. The discussion highlights the importance of diet, gut health, and the synergistic effects of flavonoids in promoting overall well-being. Professor Tups emphasizes the need for further research and clinical trials to validate the benefits of his findings. In this conversation, Alexander Tups and Lisa Tamati discuss the journey of research from the lab to market, focusing on the supplement Dahlia 4 and its potential impact on health, particularly in relation to metabolic dysregulation and neuroinflammation. They explore the importance of consumer awareness regarding supplements, the role of circadian rhythms in health, and the need for proactive health measures. The discussion emphasizes the unique mechanism of Dahlia 4 in targeting brain inflammation and its implications for conditions like Alzheimer's disease. Takeaways: Leptin and insulin play crucial roles in metabolic regulation. Neuroinflammation is a key factor in insulin resistance. Dahlia4 is a supplement derived from the Dahlia flower. Flavonoids can have synergistic effects on health. Diet and gut health significantly impact overall well-being. Research shows potential for reversing pre-diabetes. Oral hygiene is linked to brain health. Clinical trials are ongoing for Dahlia 4's effectiveness. The brain is a master organ in regulating metabolism. Natural compounds can have varying effects on health. The importance of feedback from users to improve health products. Research must translate into real-world applications for maximum impact. Basic research is crucial for developing new drugs and supplements. Supplements can be brought to market faster than traditional drugs. Consumer awareness is key in choosing effective supplements. Metabolic dysregulation is a growing concern for aging populations. Neuroinflammation may be addressed with targeted supplements. Regular eating patterns can support circadian rhythms and metabolic health. Dahlia4 targets brain inflammation, offering a unique approach. Proactive health measures can mitigate risks of chronic diseases. If you would like to try DAHLIA4 you can now find it in our range at www.lisatamati.com Dahlia4 BIO Alexander Tups pursued his academic journey in Biology, initially studying at the Heinrich Heine University of Duesseldorf and the Philipps University of Marburg. He earned a Diploma in Biology at the latter institution, focusing on Animal Physiology, Genetics, and Developmental Biology. He further advanced his education through a Marie Curie and Boehringer Ingelheim Fonds Scholarship, undertaking a Ph.D. at the Rowett Research Institute, one of the UK's leading nutrition research centres and the Philipps University of Marburg. In 2005 he graduated with "summa cum laude (highest distinction) " for his research on the neuroendocrine mechanism that regulates seasonal body weight. Following his Ph.D., Alexander Tups served as a postdoctoral fellow at the University of Otago from 2006-2008. In recognition of his potential, he received a prestigious junior group leader grant in nutrition research from the German Ministry of Education and Research in 2007, amounting to €1,500,000. This grant allowed him to establish an independent research group called 'neuronal nutrition physiology' at the Philipps University of Marburg, where he explored the impact of nutrient sensing in the brain on the regulation of body weight and glucose homeostasis as one of the youngest independent group leaders in Germany. From 2012-2014 in addition to his group leader role he was Head of Department for Animal Physiology at this institution before he was appointed at the University of Otago in 2014 in Physiology.   Throughout his career, Alex Tups has contributed significantly to his field, publishing 48 peer reviewed research papers, the vast majority as lead author. His research has contributed to our understanding of how the brain controls body weight and blood sugar levels. His work has been internationally recognized with notable awards, such as the Michael Harbuz Price in neuroendocrine research in the UK in 2009, the Ernst and Berta Sharrer Award in Germany in 2014, the Commercialisation Researcher Award at Otago University in 2023 and the Research Excellence Price by the Physiological Society of New Zealand in 2023. Alexander reviews research for leading international journals and grant agencies including for Harvard University, the British Welcome Trust and the French and German National Research Agencies. He has advised the city council of his home town, Dunedin, on the impact of artificial lighting on human Health supported by his research which contributed to the installation of modern warm street lighting in Dunedin.   His research has been funded by Return on Science, Otago Innovation, the Royal Society of Marsden Fund, the Health Research Council, the German Ministry of Research and the German Research Foundation.        Personalised Health Optimisation Consulting with Lisa Tamati Lisa offers solution focused coaching sessions to help you find the right answers to your challenges. Topics Lisa can help with:  Lisa is a Genetics Practitioner, Health Optimisation Coach, High Performance and Mindset Coach. She is a qualified Ph360 Epigenetics coach and a clinician with The DNA Company and has done years of research into brain rehabilitation, neurodegenerative diseases and biohacking. She has extensive knowledge on such therapies as hyperbaric oxygen,  intravenous vitamin C, sports performance, functional genomics, Thyroid, Hormones, Cancer and much more. She can assist with all functional medicine testing. Testing Options Comprehensive Thyroid testing DUTCH Hormone testing Adrenal Testing Organic Acid Testing Microbiome Testing Cell Blueprint Testing Epigenetics Testing DNA testing Basic Blood Test analysis Heavy Metals  Nutristat Omega 3 to 6 status and more  Lisa and her functional medicine colleagues in the practice can help you navigate the confusing world of health and medicine . She can also advise on the latest research and where to get help if mainstream medicine hasn't got the answers you are searching for whatever the  challenge you are facing from cancer to gut issues, from depression and anxiety, weight loss issues, from head injuries to burn out to hormone optimisation to the latest in longevity science. Book your consultation with Lisa    Join our Patron program and support the show Pushing the Limits' has been free to air for over 8 years. Providing leading edge information to anyone who needs it. But we need help on our mission.  Please join our patron community and get exclusive member benefits (more to roll out later this year) and support this educational platform for the price of a coffee or two You can join by going to  Lisa's Patron Community Or if you just want to support Lisa with a "coffee" go to  https://www.buymeacoffee.com/LisaT to donate $3   Lisa's Anti-Aging and Longevity Supplements  Lisa has spent years curating a very specialized range of exclusive longevity, health optimizing supplements from leading scientists, researchers and companies all around the world.  This is an unprecedented collection. The stuff Lisa wanted for her family but couldn't get in NZ that's what it's in her range. Lisa is constantly researching and interviewing the top scientists and researchers in the world to get you the best cutting edge supplements to optimize your life.   Subscribe to our popular Youtube channel  with over 600 videos, millions of views, a number of full length documentaries, and much more. You don't want to miss out on all the great content on our Lisa's youtube channel. Youtube   Order Lisa's Books Lisa has published 5 books: Running Hot, Running to Extremes, Relentless, What your oncologist isn't telling you and her latest "Thriving on the Edge"  Check them all out at  https://shop.lisatamati.com/collections/books   Perfect Amino Supplement by Dr David Minkoff Introducing PerfectAmino PerfectAmino is an amino acid supplement that is 99% utilized by the body to make protein. PerfectAmino is 3-6x the protein of other sources with almost no calories. 100% vegan and non-GMO. The coated PerfectAmino tablets are a slightly different shape and have a natural, non-GMO, certified organic vegan coating on them so they will glide down your throat easily. Fully absorbed within 20-30 minutes! No other form of protein comes close to PerfectAminos Listen to the episode with Dr Minkoff here:    Use code "tamati" at checkout to get a 10% discount on any of their devices.   Red Light Therapy: Lisa is a huge fan of Red Light Therapy and runs a Hyperbaric and Red Light Therapy clinic. If you are wanting to get the best products try Flexbeam: A wearable Red Light Device https://recharge.health/product/flexbeam-aff/?ref=A9svb6YLz79r38   Or Try Vielights' advanced Photobiomodulation Devices Vielight brain photobiomodulation devices combine electrical engineering and neuroscience. To find out more about photobiomodulation, current studies underway and already completed and for the devices mentioned in this video go to www.vielight.com and use code “tamati” to get 10% off     Enjoyed This Podcast? If you did, subscribe and share it with your friends! If you enjoyed tuning in, then leave us a review and share this with your family and friends. Have any questions? You can contact my team through email (support@lisatamati.com) or find me on Facebook, Twitter, Instagram and YouTube. For more episode updates, visit my website. You may also tune in on Apple Podcasts.  To pushing the limits, Lisa and team

Synopsis: Explore the forefront of biotech innovation as host Rahul Chaturvedi interviews Dr. Dave Bearss, Co-Founder & CEO of Halia Therapeutics, in this engaging episode of Biotech 2050. Dr. Bearss shares the story behind Halia's pioneering genetic discoveries and their mission to tackle Alzheimer's disease. Learn about the science driving breakthrough therapies that target neuroinflammation, offering hope in the fight against neurodegenerative disorders. Packed with insights and inspiration, this episode is a must-listen for anyone interested in the future of healthcare and biotech innovation. Biography: Dr. David J. Bearss, a serial entrepreneur and pharmaceutical innovator, has over two decades of experience spanning academic and industrial roles. His expertise lies at the intersection of structure-based small-molecule drug discovery and the utilization of genetic model systems for drug discovery. Dr. Bearss's career is marked by significant achievements, with a strong foundation in translational research focused on drug advancement to the clinic and using genetic markers for predictive drug sensitivity. Notably, Dr. Bearss has discovered 16 compounds that have successfully navigated from discovery in the lab to IND into clinical development. His entrepreneurial experience is evident through his roles as the co-founder of eight biotechnology companies. More importantly, his unwavering commitment to advancing novel drug development truly sets him apart. Before taking on his role as chief scientific officer at Halia in January 2021 and assuming the CEO position in March 2022, Dr. Bearss served as the CEO of Tolero Pharmaceuticals, an organization later acquired by Sumitomo Dainippon Pharma in 2017. His tenure as chief scientific officer at Montigen Pharmaceuticals, followed by its acquisition by SuperGen Inc., demonstrates his dedication to driving early-stage drug discovery and development. At SuperGen, he continued to develop his expertise in these critical areas. Dr. Bearss's academic career is equally impressive. It led to his founding role as the Center for Investigational Therapeutics Co-Director at the Huntsman Cancer Institute. He also held academic positions as an Associate Professor in the Department of Oncological Sciences at the University of Utah and as an Associate Professor of Physiology and Developmental Biology at Brigham Young University, demonstrating his deep knowledge and expertise in these fields. Dr. Bearss's academic career began with a Ph.D. in cell biology from the University of Texas Health Science Center in San Antonio, Texas, and a post-doctoral fellowship at the Institute for Drug Development at the Cancer Therapy and Research Center also in Texas. He has won several awards for his entrepreneurial and scientific achievements, including the Utah Governor's Medal of Science and BIO Utah Entrepreneur of the Year.

—--

Dr. Ardelle Piper is a Royal College Certified OB/GYN, and focuses her gynecology practice on midlife women's health. She is known as a leader and pioneer in telemedicine, and provides menopause assessments over videoconference to women across Ontario since 2020. As a subject matter expert, Dr. Piper is frequently called upon as keynote speaker to provide menopause education to medical colleagues and the community, and collaborates with other social media educators. She advocates for improved appreciation of menopause in organizations and the general public, and health education in workplace wellness programs.Dr. Piper completed a BSc(H) in Cell and Developmental Biology, then achieved her medical degree (MD) at the University of British Columbia in Vancouver in 2006. Appreciating her passion for women's health and education, she pursued an Obstetrics & Gynecology residency and a MEd in Saskatchewan, with a thesis on School Based Sexual Health Education. Through this she enjoyed leadership opportunities as a provincial representative with the Canadian Association of Interns and Residents (CAIR) and was Chair of the Junior Member Committee of the Society of Obstetricians and Gynecologists of Canada (SOGC). During her obstetrical training and career, Dr. Piper welcomed into the world over 1500 babies, and co-chaired the Management of Postpartum Hemorrhage Simulation Workshops at the Federation of International Gynecologist and Obstetricians (FIGO) World Congress in Vancouver (2015) and Brazil (2018).She realized her interest in education, advocacy, and women's health aligned perfectly with the field of Menopause, and she achieved a final year of sub-specialty training in Midlife Women's Health at The Shirley E. Greenberg Women's Health Centre in Ottawa in 2014, and has maintained NAMS Certified Menopause Practitioner status since (NCMP has now been renamed MSCP).  Her gynecology practice provides subspeciality consultation focused on menopause education, hormone therapy, sexual function, post-cancer thrivership, and preventive health promotion. With the pandemic, she has pioneered providing menopause assessments through telemedicine across Ontario. As a subject matter expert, she frequently provides menopause education to not only her physician colleagues, but also in public forums and workplaces, advocating for improved midlife women's health care.https://bywardfht.ca/our-services/menopause-clinic/https://www.instagram.com/dr.a.piper/?hl=enThank you so much for listening! I use fitness and movement to help women prevent and overcome pelvic floor challenges like incontinence and organ prolapse. There is help for women in all life stages! Every Woman Needs A Vagina Coach! Please make sure to LEAVE A REVIEW and SUBSCRIBE to the show for the best fitness and wellness advice south of your belly button. *******************I recommend checking out my comprehensive pelvic health education and fitness programs on my Buff Muff AppYou can also join my next 28 Day Buff Muff Challenge https://www.vaginacoach.com/buffmuffIf you are feeling social you can connect with me… On Facebook https://www.facebook.com/VagCoachOn Instagram https://www.instagram.com/vaginacoach/On Twitter https://twitter.com/VaginaCoachOn The Web www.vaginacoach.comGet your Feel Amazing Vaginal Moisturizer Here

WATCH: https://youtu.be/aQEX-twenkA Michael Levin is a Distinguished Professor in the Biology department at Tufts University and associate faculty at the Wyss Institute for Bioinspired Engineering at Harvard University. Prof Levin holds the Vannevar Bush endowed Chair and serves as director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. Prior to college, Michael Levin worked as a software engineer and independent contractor in the field of scientific computing. He attended Tufts University, interested in artificial intelligence and unconventional computation. To explore the algorithms by which the biological world implemented complex adaptive behavior, he got dual B.S. degrees, in CS and in Biology and then received a PhD from Harvard University. He did post-doctoral training at Harvard Medical School, where he began to uncover a new bioelectric language by which cells coordinate their activity during embryogenesis. His independent laboratory develops new molecular-genetic and conceptual tools to probe large-scale information processing in regeneration, embryogenesis, and cancer suppression. Lecture Title: "Where Minds Come From: The Scaling of Collective Intelligence. What it means for AI and You." EPISODE LINKS: - Mike's Round 1: https://youtu.be/v6gp-ORTBlU - Mike's Round 2: https://youtu.be/kMxTS7eKkNM - Mike's Round 3: https://youtu.be/1R-tdscgxu4 - Mike's Channel: https://www.youtube.com/@drmichaellevin - Mike's Website: https://drmichaellevin.org/ CONNECT: - Website: https://tevinnaidu.com - Podcast: https://podcasters.spotify.com/pod/show/drtevinnaidu - Twitter: https://twitter.com/drtevinnaidu - Facebook: https://www.facebook.com/drtevinnaidu - Instagram: https://www.instagram.com/drtevinnaidu - LinkedIn: https://www.linkedin.com/in/drtevinnaidu ============================= Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

Dr. Irving Weissman is the Virginia and Daniel Ludwig Professor of Clinical Cancer Research and Professor of Pathology and Developmental Biology at Stanford University. Dr. Weissman was the first scientist to identify and isolate mammalian blood-forming stem cells in mice, and his work has contributed to the understanding of how a single hematopoietic stem cell can give rise to specialized blood cells. He talks about developing new treatments for metastatic breast cancer and severe combined immunodeficiency. He also discusses myeloid bias in aging and strategies for commercializing new therapies.

Thomas Weimbs is a professor at the University of California in Santa Barbara (UCSB) where he directs a research laboratory focused on polycystic kidney disease (PKD). He received his doctoral degree from the University of Cologne, Germany, and then conducted postdoctoral research at the University of California in San Francisco. In 1999, he started his first independent research laboratory at the Lerner Research Institute of the Cleveland Clinic as an assistant professor. There, he started to research PKD after he was approached by a local family affected by PKD who financially supported PKD research in his newly-founded laboratory. Their family foundation still supports PKD research in Dr. Weimbs' lab today. In 2005, Dr. Weimbs moved his laboratory back to California to join the Department of Molecular, Cellular, and Developmental Biology at UCSB. His laboratory studies molecular mechanisms underlying PKD with an emphasis towards developing new therapies. Research from Dr. Weimbs' lab has led to a better understanding of PKD and led to novel methods to deliver therapeutics specifically to polycystic kidneys. Some of the most recent research has led to the discovery that dietary interventions and natural metabolites strongly slow PKD progression in animal models. This led to the launch of Santa Barbara Nutrients with the goal to make these approaches available for the nutritional management of PKD and to support kidney health. Research in Dr. Weimbs' laboratory has been funded by grants from federal agencies, including the National Institutes of Health and the Department of Defense, by private foundations, including the Lillian Goldman Charitable Trust, the Amy P. Goldman Foundation and the Jarrett Family Fund, as well as several biotech companies. For more information on research in the Weimbs lab, see https://labs.mcdb.ucsb.edu/weimbs/thomas/ In his free time (what free time?), Thomas enjoys playing the saxophone in his jazz band (no, you wouldn't have heard of them). https://labs.mcdb.ucsb.edu/weimbs/thomas/ https://santabarbaranutrients.com/ https://www.facebook.com/groups/weimbslab/ https://twitter.com/weimbslab https://www.linkedin.com/in/weimbs/   ✅ Don't forget to like, comment, share, and subscribe for more insightful content!   ✅ Brand Ambassador for Stone and Spear tallow and soaps referral link https://www.stoneandspeartallow.com/?ref=gx0gql8b Discount Code "CHAFFEE" for 10% off ✅Join my PATREON for early releases, bonus content, and weekly Zoom meetings! https://www.patreon.com/AnthonyChaffeeMD ✅Sign up for our 30-day carnivore challenge and group here! https://www.howtocarnivore.com/ ✅Stockman Steaks, Australia Discount link for home delivered frozen grass-fed and grass finished pasture raised meat locally sourced here in Australia! Use discount code "CHAFFEE" for free gift with qualifying orders! http://www.stockmansteaks.com.au/chaffee ✅ 60-minute consultation with Dr Chaffee https://calendly.com/anthonychaffeemd/60-minute-consultation   Sponsors and Affiliates: ✅ Brand Ambassador for Stone and Spear tallow and soaps referral link https://www.stoneandspeartallow.com/?ref=gx0gql8b Discount Code "CHAFFEE" for 10% off ✅ Carnivore t-shirts from the Plant Free MD  www.plantfreetees.com ✅THE CARNIVORE BAR: Discount Code "Anthony" for 10% off all orders!   https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi ✅Schwank Grill (Natural Gas or Propane) https://glnk.io/503n/anthonychaffeemd $150 OFF with Discount Code: ANTHONYMD ✅X3 bar system with discount code "DRCHAFFEE" https://www.kqzyfj.com/click-100676052-13511487 ✅Cerule Stem cells https://DrChaffee.cerule.com ✅CARNIVORE CRISPS: Discount Code "DRCHAFFEEMD" for 10% off all orders! www.carnivorecrisps.com ✅Shop Amazon https://www.amazon.com/shop/anthonychaffeemd?ref=ac_inf_hm_vp   And please like and subscribe to my podcast here and Apple/Google podcasts, as well as my YouTube Channel to get updates on all new content, and please consider giving a 5-star rating as it really helps!   This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.   This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Dietary and lifestyle changes are only part of the complete health picture, the impact of which will depend on each person's individual circumstances. It is important to stay under the care of appropriate health care professionals, whose advice should be sought before making any substantial dietary or other changes.   Music Credit: Music by: bensound.com License code: MPTEUCI8DAXJOKPZ Music: bensound.com License code: FJQPPMCJLHEOYGQB Music: Bensound.com/royalty-free-music License code: KQAKMWSXIH3MJ4WX Music I use: https://www.bensound.com License code: 58NN4QOSKWJ7ASX9   

Liza Konnikova, MD, PhD, FAAP, is a neonatologist at UPMC Children's Hospital of Pittsburgh and an assistant professor in the Departments of Pediatrics, Developmental Biology and Immunology in the University of Pittsburgh School of Medicine. Her lab focuses on the develop of neonatal immunity at mucosal surfaces and its role in the pathogenesis of diverse diseases such as sepsis, preterm labor, necrotizing enterocolitis, and very-early onset IBD (VEO-IBD). She has pioneered the application of mass cytometry to frozen mucosal biopsies, helping to improve our understanding of mucosal immunity. This innovation has helped to identify novel populations of immune cells in VEO-IBD and to perform serial monitoring of IBD activity during drug trials.

Michael Levin is a Distinguished Professor in the Biology department at Tufts University and associate faculty at the Wyss Institute for Bioinspired Engineering at Harvard University. He holds the Vannevar Bush endowed Chair and serves as director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. Prior to college, Michael Levin worked as a software engineer and independent contractor in the field of scientific computing. He attended Tufts University, interested in artificial intelligence and unconventional computation. To explore the algorithms by which the biological world implemented complex adaptive behavior, he got dual B.S. degrees, in CS and in Biology and then received a PhD from Harvard University. He did post-doctoral training at Harvard Medical School, where he began to uncover a new bioelectric language by which cells coordinate their activity during embryogenesis. His independent laboratory develops new molecular-genetic and conceptual tools to probe large-scale information processing in regeneration, embryogenesis, and cancer suppression. TIMESTAMPS: (0:00) - Introduction (1:41) - Creating High-level General Intelligences (7:00) - Ethical implications of Diverse Intelligence beyond AI & LLMs (10:30) - Solving the Fundamental Paradox that faces all Species (15:00) - Evolution creates Problem Solving Agents & the Self is a Dynamical Construct (23:00) - Mike on Stephen Grossberg (26:20) - A Formal Definition of Diverse Intelligence (DI) (30:50) - Intimate relationships with AI? Importance of Cognitive Light Cones (38:00) - Cyborgs, hybrids, chimeras, & a new concept called "Synthbiosis" (45:51) - Importance of the symbiotic relationship between Science & Philosophy (53:00) - The Space of Possible Minds (58:30) - Is Mike Playing God? (1:02:45) - A path forward: through the ethics filter for civilization (1:09:00) - Mike on Daniel Dennett (RIP) (1:14:02) - An Ethical Synthbiosis that goes beyond "are you real or faking it" (1:25:47) - Conclusion EPISODE LINKS: - Mike's Round 1: https://youtu.be/v6gp-ORTBlU - Mike's Round 2: https://youtu.be/kMxTS7eKkNM - Mike's Website: https://drmichaellevin.org/ - Blog Website: https://thoughtforms.life - Mike's Publications: https://scholar.google.com/citations?user=luouyakAAAAJ&hl=en - Mike's NOEMA piece: https://www.noemamag.com/ai-could-be-a-bridge-toward-diverse-intelligence/ - Stephen Grossberg: https://youtu.be/bcV1eSgByzg - Mark Solms: https://youtu.be/rkbeaxjAZm4 - VPRO Roundtable: https://youtu.be/RVrnn7QW6Jg?feature=shared CONNECT: - Website: https://tevinnaidu.com - Podcast: https://podcasters.spotify.com/pod/show/drtevinnaidu - Twitter: https://twitter.com/drtevinnaidu - Facebook: https://www.facebook.com/drtevinnaidu - Instagram: https://www.instagram.com/drtevinnaidu - LinkedIn: https://www.linkedin.com/in/drtevinnaidu ============================= Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

Michael Levin is an American developmental and synthetic biologist at Tufts University, where he is the Vannevar Bush Distinguished Professor. Levin is a director of the Allen Discovery Center at Tufts University and Tufts Center for Regenerative and Developmental Biology. He is also co-director of the Institute for Computationally Designed Organisms with Josh Bongard. Please consider signing up for TOEmail at https://www.curtjaimungal.org  Support TOE: - Patreon: https://patreon.com/curtjaimungal (early access to ad-free audio episodes!) - Crypto: https://tinyurl.com/cryptoTOE - PayPal: https://tinyurl.com/paypalTOE - TOE Merch: https://tinyurl.com/TOEmerch  Follow TOE: - *NEW* Get my 'Top 10 TOEs' PDF + Weekly Personal Updates: https://www.curtjaimungal.org - Instagram: https://www.instagram.com/theoriesofeverythingpod - TikTok: https://www.tiktok.com/@theoriesofeverything_ - Twitter: https://twitter.com/TOEwithCurt - Discord Invite: https://discord.com/invite/kBcnfNVwqs - iTunes: https://podcasts.apple.com/ca/podcast/better-left-unsaid-with-curt-jaimungal/id1521758802 - Pandora: https://pdora.co/33b9lfP - Spotify: https://open.spotify.com/show/4gL14b92xAErofYQA7bU4e - Subreddit r/TheoriesOfEverything: https://reddit.com/r/theoriesofeverything  

Dr. Shankar Srinivas is a Professor of Developmental Biology in the Department of Physiology Anatomy and Genetics based in the Institute for Developmental and Regenerative Medicine at the University of Oxford. He is also a Zeitlyn Fellow and Tutor in Medicine at Jesus College. Using mouse and human embryos as model systems, his group looks at the control of patterning and morphogenesis during the establishment of the anterior-posterior axis, gastrulation, and early cardiogenesis.  He discusses how tissues respond to forces during early development, characterizing cardiac progenitors, and his experience training internationally.

Thank you for joining us for another episode of the Low Carb MD Podcast. Dr. Thomas Weimbs received his doctoral degree from the Department of Biochemistry of the University of Cologne, Germany, in 1993. He conducted postdoctoral research at the Department of Anatomy, University of California at San Francisco until 1999. In the same year, he joined the Department of Cell Biology in the Lerner Research Institute of the Cleveland Clinic as an Assistant Professor where he established his research laboratory focusing on investigating membrane trafficking and epithelial cell polarity as well as molecular mechanisms underlying polycystic kidney disease. In 2005, Dr. Weimbs was recruited to the Department of Molecular, Cellular, and Developmental Biology and moved his laboratory to UCSB. Dr. Weimbs is currently an Associate Professor in MCDB and in the Neuroscience Research Institute. In this episode, Drs. Tro and Thomas talk about how Dr. Thomas became interested in researching PKD (Polycystic Kidney Disease), what PKD is, research that Dr. Thomas has done on the impact of ketosis on PKD, a recently published paper on the negative impact of the ketogenic diet on kidney health, how Dr. Thomas' colleagues have reacted to his research, and lifestyle intervention programs using ketogenic metabolic therapy. For more information, please see the links below. Thank you for listening! Links: Dr. Thomas Weimbs: Weimbs Lab Twitter Research LinkedIn Facebook Group Santa Barbara Nutrients Dr. Brian Lenzkes: Website Twitter Dr. Tro Kalayjian: Website Twitter Instagram Doctor Tro App Join a growing community of individuals who are improving their metabolic health; together. Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more. Apple Google Learn more